ARCHIVES

Ethicists dispute von Eschenbach’s claim that his NCI-FDA conflicts are managed. NCI-FDA chief appears to cite Klausner-era “in-box rule.”

This article is from The Cancer Letter archive.

Vol. 31 No. 46 | December 16, 2005

Download PDF Visit The Full Archive

Related Articles

Letters: Alternatives Needs Scrutiny, Investigator Open-Mindedness

December 3, 1993

Vaccine Increases PFS by 4 Months In Phase II Per-Protocol Analysis

June 27, 2014

Facing Congressional Criticism, NIH Starts Review of Extramural Conflict Policies.

June 13, 2008

Consensus Panel Determines Total Mastectomy Plus Node Dissection “Satisfactory Alternative” To Radical Mastectomy

June 15, 1979

In Brief: Dickersin Named To NCAB; Gallo To Retire; FASEB Suggests 10% Increase For NIH

January 20, 1995

Regulatory Agencies: FDA To Increase Fees For Mammography Facility Inspections

January 30, 1998